Tevogen Bio board to evaluate potential one-time special cash dividend after unspecified milestones

Tevogen Bio Holdings Inc.

Board intends to evaluate a special cash dividend contingent on future financial milestones (revenue, earnings targets).
No dividend has been declared; any declaration subject to financial performance, solvency laws, and board approval.
No assurance can be given on timing, amount, or whether a dividend will occur at all.
Company plans to provide further updates as appropriate under disclosure requirements.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.